The fascial system constitutes a complex and highly intricate network within the body, consisting of both superficial and deep layers. While fascial dysfunction is commonly linked to musculoskeletal discomfort, it may also play a role in other nonspecific pain conditions, such as irritable bowel syndrome (IBS). In the approach discussed here, glucopuncture (GP) involves the injection of a 5% glucose (or 5% dextrose) solution directly into the superficial fascia to alleviate discomfort in nonspecific pain syndromes. This article describes a case where a patient underwent patient-directed GP as a treatment for IBS. It is crucial to ensure that other conditions, such as colorectal cancer, are excluded beforehand. This case emphasizes the potential of patient-directed GP as an affordable technique for managing nonspecific abdominal pain. However, further studies are essential to thoroughly evaluate the effectiveness and safety of GP for addressing such vague pain conditions.